Related content

Letrozole: An Updated Review of its Use in Postmenopausal Women with Advanced Breast Cancer

By Keating G.M.   Jarvis B.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 351-371

Adis International

Access to resources Recommend Favorite

Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Aminoglutethimide: a Phase II Multicentre Multinational Study

By Exemestane Study Group   Thurlimann B.   Paridaens R.   Serin D.   Bonneterre J.   Roche H.   Murray R.   di Salle E.   Lanzalone S.   Zurlo M.G.   Piscitelli G.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1767-1773

Elsevier

Access to resources Recommend Favorite

Treatment Options For Postmenopausal Women with Tamoxifen-Resistant Advanced Breast Cancer

By Cheung K-L.   Robertson J.F.R.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite

Effect of letrozole on the lipid profile in postmenopausal women with breast cancer

By Elisaf M.S.   Bairaktari E.T.   Nicolaides C.   Kakaidi B.   Tzallas C.S.   Katsaraki A.   Pavlidis N.A.  

European Journal of Cancer, Vol. 37, Iss. 12, 2001-08 ,pp. : 1510-1513

Elsevier

Access to resources Recommend Favorite

Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age

By Rose C.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 2, 2000-05 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite